Skip to main content
OpenTrials

Clinical trial condition

Tumor Virus Infections

Explore clinical trials studying Tumor Virus Infections. Study availability and eligibility vary by location and protocol.

1,486 public trials 253 recruiting studies
Refine in advanced search Browse all conditions

Tumor Virus Infections trial results

Completed

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

NCT00001337

Conditions
Anaplastic Large-Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +21 more
Locations
  • Holy Cross Hospital, Fort Lauderdale Fort Lauderdale, Florida, United States
  • University of Maryland, Baltimore Baltimore, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Efficacy of Probiotic Lactobacillus Crispatus M247 in Promoting High-risk Human Papillomavirus (HR-HPV) Infection Clearance and Modifying Vaginal Microbiota

NCT06802809

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations
  • Azienda Ospedaliero Universitaria Policlinico "G. Rodolico-San Marco" Catania, Italy
  • Nuovo Ospedale di Lentini Lentini, Italy
  • Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo Palermo, Italy
View Trial Details
Completed

Immunogenicity and Safety of the 9-valent Human Papillomavirus (9vHPV) Vaccine in Japanese Boys and Girls (V503-066)

NCT04772534

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +10 more
Locations
  • Sotobo Children's Clinic ( Site 6616) Isumi, Chiba, Japan
  • Ohigesenseino Kodomo Clinic ( Site 6607) Sapporo, Hokkaido, Japan
  • Motomachi Pediatric Clinic ( Site 6606) Sapporo, Hokkaido, Japan
  • Medical Corporation Bunmeikai Okuda E.N.T ( Site 6611) Sakai, Osaka, Japan
View Trial Details
Completed

Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913)

NCT03783078

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +15 more
Locations
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0006) New York, United States
  • Icahn School of Medicine at Mount Sinai ( Site 0004) New York, United States
  • Melanoma Institute Australia ( Site 0400) North Sydney, New South Wales, Australia
  • Calvary Mater Newcastle ( Site 0402) Waratah, New South Wales, Australia
View all 22 locations
View Trial Details

Related conditions